Aims/hypothesis Evidence has suggested that low serum potassium concentrations decrease insulin secretion, leading to glucose intolerance, and that hypokalaemia induced by diuretics increases the risk for diabetes in hypertensive individuals. However, no prospective study has investigated the association between serum potassium and the development of type 2 diabetes in a healthy cohort comprised of Asian individuals not being administered antihypertensive medications. This study aimed to investigate whether low serum potassium is associated with increased risk of type 2 diabetes in apparently healthy Japanese men. Methods We followed 4,409 Japanese men with no history of diabetes, use of antihypertensives, renal dysfunction or liver dysfunction (mean ± SD age, 48.4±8.4 years). Cox proportional hazards regression was used to estimate HRs for incident diabetes (fasting plasma glucose level ≥7.0 mmol/l, HbA 1c ≥6.5% or self-reported) including serum potassium concentration as either a categorical or a continuous variable.
Introduction
Evidence has suggested that hypokalaemia or decreased serum potassium induced by diuretics is related to impaired glucose tolerance and increased risk of diabetes in hypertensive individuals [1, 2] . Low serum potassium approximates body potassium depletion, which is difficult to assess clinically [3] . In a small number of healthy individuals experimentally placed on a low-potassium diet, significant falls in serum potassium and total body potassium (TBK) were suggested to induce glucose intolerance associated with impaired insulin secretion [4, 5] , which is controlled by ATP-sensitive potassium channels [6] . A large cohort study showed an inverse association between dietary potassium intake and risk of type 2 diabetes [7] . More recently and concomitantly with the performance of our study, an inverse association of serum potassium and increased risk of type 2 diabetes independent of diuretic use was reported in white Americans and African-Americans [8] . However, until the present report, this issue was not studied in Asians. We examined whether low serum potassium was associated with an increased risk of type 2 diabetes in apparently healthy Japanese men without dietary restrictions.
Methods
The Toranomon Hospital Health Management Center Study (TOPICS) included apparently healthy Japanese government employees who underwent annual multiphasic health screening examinations. Each examination included biochemical tests and standard questionnaires on demographic characteristics, medical history and health-related habits. The study attempted to elucidate the incidence of and risk factors for various diseases among the Japanese population. Data were collected on 21,362 men and 8,222 women who had baseline examinations from 1997 to 2002. For our purpose, we analysed data on 5208 men who received four or more annual examinations during a 5 year follow-up. There were too few incident cases of diabetes among women for a meaningful analysis (27/1513 women after exclusions).
Diabetes was defined according to ADA criteria of fasting plasma glucose (FPG) ≥7.0 mmol/l, self-reported cliniciandiagnosed diabetes or HbA 1c level ≥6.5% [9] . Reasons for exclusion were diabetes at the baseline examination (n=278), taking antihypertensive medication (n=453), renal dysfunction (serum creatinine level >177 μmol/l, n=3), liver dysfunction (under outpatient treatment, n=116) or missing data on baseline characteristics (n=59). Data from 4,409 men aged 25-80 years were eligible for analysis.
Overnight fasting blood samples were immediately placed into Vacutainer tubes and spun in a cold centrifuge. Serum potassium concentration was measured by the ionselective electrode method (Hitachi 008, Tokyo, Japan). Individuals were categorised into tertiles of serum potassium distribution. For comparison, data were analysed in four groups according to equal intervals of 0.3 mmol/l serum potassium (<3.7, 3.7-3.9, 4.0-4.2 and ≥4.3 mmol/l) based on our institute's normal range (3.7-4.8 mmol/l). The association of change in serum potassium during follow-up with risk of type 2 diabetes was also investigated.
Statistical analysis HRs and 95% CIs were estimated by Cox regression for each serum potassium category using the highest tertile (4.2-5.4 mmol/l) as the reference or potassium as a continuous variable. Follow-up time was calculated from the first examination to the date of confirmed diabetes or last follow-up examination. Tests for linear trends across increasing categories of serum potassium concentrations treated categories as continuous variables in a model. Changes in serum potassium from baseline were calculated only when data for 5 years of follow-up were available (2,594 men and 176 incident cases). SPSS version 17.0 (SPSS, Chicago, IL, USA) was used for statistical analysis; p<0.05 indicated statistical significance.
Informed consent was obtained from all participants. The study protocol followed the Japanese Government's Ethical Guidelines Regarding Epidemiological Studies in accordance with the Declaration of Helsinki and was reviewed by the Institutional Review Board at Toranomon Hospital.
Results
During 5 years of follow-up (median 4.98 years, 21,094 person-years), we documented 250 incident cases of type 2 diabetes (32% by self-report; 68% by FPG and/or HbA 1c ). No correlation between serum potassium at baseline and BMI gain during follow-up was revealed (p=0.928). Older age was associated with higher serum potassium. The association between serum potassium and glucose or HbA 1c was attenuated after adjustment for age or a stratified analysis (Table 1) .
Lower tertiles compared with the highest tertile of serum potassium trended to be associated with a higher HR for incident type 2 diabetes, but without statistical significance in the age-adjusted model ( Table 2 ). The HR in the lowest tertile (2.8-3.9 mmol/l) became statistically significant after adjustment for HbA 1c , and the lowest tertile of serum potassium was associated with an increased risk independent of traditional predictors. A similar association was observed for categories of equal intervals of 0.3 mmol/l of serum potassium. Results for lower values (<3.7 mmol/l) within the first tertile (2.8-3.9 mmol/l) were associated with even greater risk. The association between serum potassium and risk of diabetes was fundamentally the same when HbA 1c values were not included among criteria for type 2 diabetes. Among the entire group (4,423 men) there were 230 incident cases of diabetes. Multivariate-adjusted HR for the lowest compared with the highest tertile was 1.74 (1.25-2.41).
Cox analysis with potassium as a continuous variable showed that every 0.5 mmol/l lower serum potassium level at baseline was associated with a 45% (12-87%) higher risk of type 2 diabetes in the entire group (multivariate + HbA 1c and FPG model). When individuals were stratified according to baseline prediabetic state, low potassium levels were signifi-cantly associated with an increased risk of type 2 diabetes, particularly among prediabetic individuals at baseline.
During follow-up, 315 individuals began antihypertensive therapy, but results differed little from those not taking antihypertensives. There was a 50% (15-96%) adjusted increased risk for each 0.5 mmol/l lower increment of serum potassium at baseline.
Quintile distribution of serum potassium changes suggested that larger decreases in serum potassium after baseline were associated with increasingly higher incident rates regardless of baseline serum potassium (quintile [Q] 1 less than −0.1 mmol/l, 9.0%; Q2 −0.1-0.0 mmol/l, 8.6%; Q3 0.1 mmol/l, 6.7%; Q4 0.2 mmol/l, 5.6%; and Q5 ≥0.3 mmol/l, 4.7%; p=0.001 for trend).
Discussion
This prospective study showed an association between lower serum potassium and increased risk of type 2 diabetes in Japanese men not using antihypertensive medications. Also, the results suggested hypokalaemia as a possible factor in progression from a prediabetic state to type 2 diabetes.
Our results coincide with studies of both hypertensive and healthy individuals [1, 2, 4, 5, 8] . Among hypertensive patients, every 0.5 mmol/l decrease induced by diuretics was associated with a 45% higher risk of diabetes [2] . Maintaining serum potassium above 4.0 mmol/l was reported to be useful in preventing thiazide-induced diabetes [1] .
Glucose intolerance associated with decreased insulin secretion was induced in healthy individuals placed in a hypokalaemic state (2.4-3.6 [4] or 2.4-3.5 mmol/l by dietary restrictions [5] ). The Atherosclerosis Risk in Communities (ARIC) study of white Americans and African-Americans in the USA [8] reported an independent association of low-normal serum potassium (2.5-5.0 mmol/l) with development of type 2 diabetes compared with highnormal levels (5.0-5.5 mmol/l), while our results showed an independent association of values <4.0 mmol/l with an increased risk of type 2 diabetes. Our results for an Asian study population agree with the results from the US study that a mild-to-moderate decrease in serum potassium, even within Being normoglycaemic, the majority of our study participants were assumed to have normal insulin secretion at baseline. However, that early-phase insulin decreased progressively when FPG exceeded 5.6 mmol/l indicates an important role for early-phase insulin secretion in the development of glucose intolerance, specifically in Asians [10] . Therefore, hypokalaemia could influence the development of type 2 diabetes among prediabetic individuals, that is, those having metabolic abnormalities of reduced TBK and diminished insulin secretion. In addition, as HbA 1c reflects chronic hyperglycaemia rather than acute dysglycaemia, robust results might be shown after adjustment for HbA 1c .
Low dietary potassium intake of 40 mmol/day resulted in a significant fall in serum potassium and TBK, leading to glucose intolerance in normal individuals [4] . Theoretically, a 0.3 mmol/l decrease in serum potassium corresponds to a 100 mmol reduction in TBK on average [3] . However, because redistribution between extracellular and intracellular spaces also influences serum potassium, hypokalaemia should be considered to coexist with normal body potassium levels. As TBK values were unavailable, we could not address the role of TBK. However, we found that in Japanese men without dietary restrictions, serum potassium, a widely available measurement in clinical practice, was associated with incident type 2 diabetes.
The study strengths were the large sample size, strict exclusion criteria, especially excluding those taking diuretics at baseline, and the availability of HbA 1c data. The limitations were that all participants were men, neither serum magnesium nor insulin was measured and information on potassium supplementation or dietary intake was unavailable. Whether poor dietary potassium intake affected serum potassium and subsequently influenced our results could not be determined, although no independent association between dietary potassium intake and risk of diabetes has been shown [8] . Factors such as lifestyle might have influenced results. That managing serum potassium is effective in preventing diabetes cannot be confirmed from the present results. Further research is required. Also, the association between changes in serum potassium and risk of diabetes in healthy individuals should be studied.
In conclusion, low serum potassium even within the normal range could be predictive of type 2 diabetes in healthy Japanese men not using antihypertensive medications. This association might be universal, regardless of ethnicity.
